Atlas Trials

Multiple Dose Study to Determine Safety and Tolerability of ESK-001 in Healthy Participants

Clinical trial NCT05431634 · COMPLETED

Trial details

NCT number
NCT05431634
Sponsor
Alumis Inc
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Safety and Tolerability
Start date
2022-05-12
Primary completion
2022-12-01
Enrollment
49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.